DKK1 and neoplasm: DKK1 has been found to be hypermethylated in several types of tumors, and its tumor suppressor activity can be reversed using demethylation agents40,41, suggesting that hypermethylation of this gene may be a new therapeutic target in metastatic-competent CTCs.